---

$6.57

-0.2260 ( -3.32% ) 182.7K

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-01-24	Sale	-6609.00	Feder Julie B
2023-11-09	Buy	76000.00	Johnson David Michael
2023-11-09	Buy	1560000.00	Matrix Capital Management Company, LP
2023-11-07	Sale	-3800.00	de los Pinos Elisabet
2023-11-07	Sale	-3900.00	Feder Julie B
2023-11-03	Sale	-135000.00	Hopkins Janet Jill
2023-11-01	Sale	-3385.00	Feder Julie B
2023-11-01	Sale	-9586.00	de los Pinos Elisabet
2023-10-05	Buy	13500.00	Johnson David Michael